The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
30 09 2021
30 09 2021
Historique:
received:
25
03
2021
accepted:
26
08
2021
entrez:
1
10
2021
pubmed:
2
10
2021
medline:
21
10
2021
Statut:
epublish
Résumé
The germicidal potential of specific wavelengths within the electromagnetic spectrum is an area of growing interest. While ultra-violet (UV) based technologies have shown satisfactory virucidal potential, the photo-toxicity in humans coupled with UV associated polymer degradation limit their use in occupied spaces. Alternatively, longer wavelengths with less irradiation energy such as visible light (405 nm) have largely been explored in the context of bactericidal and fungicidal applications. Such studies indicated that 405 nm mediated inactivation is caused by the absorbance of porphyrins within the organism creating reactive oxygen species which result in free radical damage to its DNA and disruption of cellular functions. The virucidal potential of visible-light based technologies has been largely unexplored and speculated to be ineffective given the lack of porphyrins in viruses. The current study demonstrated increased susceptibility of lipid-enveloped respiratory pathogens of importance such as SARS-CoV-2 (causative agent of COVID-19) and influenza A virus to 405 nm, visible light in the absence of exogenous photosensitizers thereby indicating a potential alternative porphyrin-independent mechanism of visible light mediated viral inactivation. These results were obtained using less than expected irradiance levels which are considered safe for humans and commercially achievable. Our results support further exploration of the use of visible light technology for the application of continuous decontamination in occupied areas within hospitals and/or infectious disease laboratories, specifically for the inactivation of respiratory pathogens such as SARS-CoV-2 and Influenza A.
Identifiants
pubmed: 34593848
doi: 10.1038/s41598-021-97797-0
pii: 10.1038/s41598-021-97797-0
pmc: PMC8484654
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
19470Informations de copyright
© 2021. The Author(s).
Références
ACS Appl Mater Interfaces. 2020 Aug 5;12(31):34723-34727
pubmed: 32657566
PLoS Med. 2020 Sep 22;17(9):e1003346
pubmed: 32960881
J Hosp Infect. 2020 Oct;106(2):226-231
pubmed: 32652214
Drug Resist Updat. 2012 Aug;15(4):223-36
pubmed: 22846406
Photochem Photobiol. 2013 Jan-Feb;89(1):120-6
pubmed: 22803813
Food Environ Virol. 2017 Jun;9(2):159-167
pubmed: 28040848
Virology. 2005 Oct 25;341(2):321-9
pubmed: 16099012
mSphere. 2020 Jul 1;5(4):
pubmed: 32611701
Fungal Biol. 2013 Jul-Aug;117(7-8):519-27
pubmed: 23931117
Pathogens. 2020 Sep 08;9(9):
pubmed: 32911671
Photodiagnosis Photodyn Ther. 2015 Sep;12(3):385-92
pubmed: 26117199
BMC Infect Dis. 2011 Dec 22;11:354
pubmed: 22192363
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
Sci Total Environ. 2019 Jun 25;671:59-65
pubmed: 30927728
J Photochem Photobiol B. 2017 Feb;167:150-157
pubmed: 28064075
Photochem Photobiol. 2012 Jul-Aug;88(4):1001-4
pubmed: 22458545
Vaccine. 2008 Sep 12;26 Suppl 4:D49-53
pubmed: 19230160
J Vis Exp. 2010 Aug 03;(42):
pubmed: 20729804
Lancet Microbe. 2020 Aug;1(4):e145
pubmed: 33521711
Sci Rep. 2021 Oct 7;11(1):19970
pubmed: 34620951
PLoS Med. 2009 Mar 17;6(3):e43
pubmed: 19296717
J Hosp Infect. 2020 Mar;104(3):246-251
pubmed: 32035997
J Infect Dis. 2020 Jul 23;222(4):564-571
pubmed: 32525979
Virulence. 2012 Jul 1;3(4):351-67
pubmed: 22722247
FEMS Microbiol Lett. 2008 Aug;285(2):227-32
pubmed: 18557942
Elife. 2020 Apr 02;9:
pubmed: 32228860
Virol J. 2014 Feb 05;11:20
pubmed: 24495489
J Hosp Infect. 2018 Jan;98(1):67-73
pubmed: 28716671
Clin Infect Dis. 2004 Sep 1;39(5):702-9
pubmed: 15356786
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Bacteriophage. 2014 Jul 28;4:e32129
pubmed: 25101216
Transbound Emerg Dis. 2021 Mar;68(2):296-312
pubmed: 32603505
Emerg Microbes Infect. 2020 Dec;9(1):1415-1417
pubmed: 32496967
J Hosp Infect. 2010 Nov;76(3):247-51
pubmed: 20864210
J Hosp Infect. 2014 Sep;88(1):1-11
pubmed: 25066049
Sci Rep. 2017 Sep 20;7(1):11951
pubmed: 28931903
Am J Infect Control. 2019 Jul;47(7):804-810
pubmed: 30638672
Cornea. 2021 Jan;40(1):121-122
pubmed: 32355114
J Occup Environ Hyg. 2007 Jun;4(6):400-5
pubmed: 17474029